Our monocytic MDSC assay helps predict responses to immune checkpoint inhibitors and improve patient stratification by accurately monitoring monocytic MDSC (mMDSC).
This case study provides details on our uniform methodology to quantify mMDSC, including:
Flow cytometry provides an unrivalled view of the cellular immune response to cancer, measuring key peripheral immune cells. With years of expertise and deep knowledge of the technology, scientists at CellCarta work closely with clients to provide rapid and accurate immune profiling.